Please anonymize the following text: 



Record date: 2090-11-21


CC: recent hospitalization and f/up of DM and HTN management


HPI: 62 yo female who presents back to clinic after recent hospitalization 11/13-11/16 with
atypical chest pain.  She underwent evaluation with MR stress test which revealed inferior
ischemia.  Underwent cath and RCA stent placement.  Since then, pt reports some mild
SOB and CP only once shortly 1 day after discharge.  No headaches.
Denies any symptoms of hyperglycemia or hypoglycemia.



Problems
Menopause at age 52 
H/O R sided sciatica 
H/O pneumonia 1/2082 
S/P vocal cord cyst removal 
S/P cholecystectomy 
S/P C section x 2 
Diabetes mellitus type 2 : onset 2067
Severe nonproliferative diabetic retinopathy with severe macular edema 
H/O pyelonephritis 
1/16/88 cardiac MIBI with summed stress score of 0 but evidence of extensive calcified coronary plaque burden with coronary calcium score of 715 
Hypertension 
Depression 
7/23/88 R shoulder arthroscopy 
4/20/89 lumbar CT : No stenosis or disc herniation, mild deg changes of the lower lumbar spine as described with a possible tiny lateral disc protrusion on the L at L3-L4.

CAD s/p RCA stent placement 11/2090


Medications
Amitriptyline HCL 25 MG (25MG TABLET Take 1) PO QHS PRN neuropathic pain , for pain - para el dolor #30 Tablet(s)
Cozaar (LOSARTAN) 100MG TABLET Take 1 PO QD #30 Tablet(s)
Darvocet N 100 (PROPOXYPHENE NAP/ACETAMIN... 1 TAB PO BID PRN pain - dolor #60 Tablet(s)
Ecasa (ASPIRIN ENTERIC COATED) 325 MG (325MG TABLET Take 1) PO QD #30 Tablet(s)
Ergocalciferol 50000 UNITS (50000 UNIT CAPSULE Take 1) PO QWEEK #1 Month(s) Supply
Lantus (INSULIN GLARGINE) 88 UNITS SC QAM #1 Month(s) Supply
Lasix (FUROSEMIDE) 20 MG (20MG TABLET Take 1) PO QD #1 Month(s) Supply
Lipitor (ATORVASTATIN) 80 MG (80MG TABLET Take 1) PO QD #30 Tablet(s)
Lisinopril 5 MG (5MG TABLET Take 1) PO QD x 30 days #30 Tablet(s)
Neurontin (GABAPENTIN) 300 MG (300MG CAPSULE Take 1) PO BID #60 Tablet(s)
Niaspan (NICOTINIC ACID SUSTAINED RELEASE) 1000 MG (1000MG TABLET SA Take 1) PO QHS #90 Tablet(s)
Nifedipine (EXTENDED RELEASE) 60 MG (60MG TABLET Take 1) PO QPM x 30 days #30 Tablet(s)
Paxil (PAROXETINE) 20MG TABLET Take 1 Tablet(s) PO QD #30 Tablet(s)
Plavix (CLOPIDOGREL) 75 MG (75MG TABLET Take 1) PO QD #30 Tablet(s)
Prilosec (OMEPRAZOLE) 20 MG (20MG CAPSULE DR Take 1) PO QD , before eating #30 Capsule(s)
Toprol XL (METOPROLOL SUCCINATE EXTENDED RELEASE) 200 MG (200MG TAB.SR 24H Take 1) PO QD #30 TAB.SR




Allergies
NKA 


PEx: Vital Signs: BP 117/56, P 67, Wt 184.6 lbs
WDWN older female in NAD.  
HEENT: anicteric sclerae  
Neck: supple, no JVD.  
Lungs: CTA.  
CV: RRR, s1s2, nl, II/VI SEM at LSB
Abd: soft, NT  
Ext: no c/c/bil 1+ edema.  


A/P:
1. HTN/CHF.  BP improved with newer medical regimen since discharge,
scheduled for Cards f/up 12/91, now on Plavix.  Dietary and exercise rec's reviewed.
Counseling given regarding recent RCA stent placement.

2. DM, stable, recent A1C 9.1 on 11/14/90, increased Lantus to 88 units as directed 
and dietary rec's reviewed.  Following.
3. Scheduled for renal evaluation 12/14/90.


Singh, M.D.





1. H/O pneumonia 1/2082 
2. S/P vocal cord cyst removal 
3. S/P cholecystectomy 
4. S/P C section x 2 
5. Diabetes mellitus type 2 : onset 2067
6. Severe nonproliferative diabetic retinopathy with severe macular edema 
7. H/O pyelonephritis 
8. 1/16/88 cardiac MIBI with summed stress score of 0 but evidence of extensive
calcinated coronary plaque burden with coronary calcium score of 715 
9. Hypertension 
10. Depression. 7/23/88 R shoulder arthroscopy
11. 4/20/89 lumbar CT : No stenosis or disc herniation, mild deg changes of the lower
lumbar spine as described with a possible tiny lateral disc protrusion on the L at L3-L4.

CAD s/p RCA stent placement 11/2090


Medications
1. Amitriptyline HCL 25MG (25MG TABLET Take 1 PO QHS PRN neuropathic pain, for pain -
para el dolor  #30 Tablet(s))
2. Cozaar (LOSARTAN) 100MG (100MG TABLET Take 1 PO QD PRN #30 Tablet(s))
3. Darvocet N 100 (PROPOXYPHENE NAP/ACETAMIN/500MG TABLET Take 1 PO BID PRN pain -
dolor #60 Tablet(s))
4. Ecasa (ASPIRIN ENTERIC COATED) 325MG (325MG TABLET Take 1 PO QD PRN pain - dolor #60 Tablet(s))
5. Ergocalciferol 50000 UNITS (50000 UNIT CAPSULE Take 1 PO QWEEK PRN #1 Month(s) Supply)
6. Lantus (INSULIN GLARGINE) 88 UNITS SC QAM PRN #1 Month(s) Supply
7. Lasiix (FUROSEMIDE) 20MG (20MG TABLET Take 1 PO QD PRN pain - dolor  #30 Tablet(s))
8. Lipitor (ATORVASTATIN) 80MG (80MG TABLET Take 1 PO QD PRN for hyperlipidemia #30 Tablet(s))
9. Lisinopril 5MG (5MG TABLET Take 1 PO QD for hypertension #30 Tablet(s))
10. Niaspan (NICOTINIC ACID SUSTAINED RELEASE) 1000MG (1000MG CAPSULE Take 1 PO QAM PRN for hyperlipidemia  #30 Tablet(s))
11. Nifedipine 300MG (300MG CAPSULE Take 1 PO QAM PRN  #60 Tablet(s))
12. Neurontin 300 MG (300MG Tablet(s))
13. Niacetamine 500 MG (500MG TABLET Take 1 PO QD PRN #90 Tablet(s))
14. Niaspan 340 MG TABLET(s)



Severe 

E

Lisinibetan.




H



Hgb


Lasib
Hb






Tx


Ps






Sever 

Sever
H




MRISB 

T
T
 



T
S.
Hospital



Hospital
T
Tx

T with MRIx. 
M



MRIx
Hospital
P 2012 0, Hx-T. 
10.


Tx.
T
T.
H. 
Hospital 1

M with.  Tx
M.
11 
1. 97

A-
T1.
Hx

Hospital 
S

P 
T
20
 2

M
1.
110

Medic, 20108-1201. 7
H.H 3, 1 month and 9-5
M.





The
10.
1 month
112 week with 2 weeks. 9, 1/11 year. 7

follow and 2 for a week.
2 and age. (10020. 50
A week. The 1453008205366989. It, and the: and... ( and: : :12, 23 year and date, date. A,  in the: The: 1. The 18, and 1217025 year. for old for 0 year. for the week (year.233 for the for a,488295126 for :3, for the:3 for 129919324763215: a:A for: a with a for the for a. (follow forge for a for the for:2 following after for the year a: in a for the for a forstand for this for a for a for  for this for the forced for. and a for a for for a for the 1415131193 was for was for -1 and  in. (3 from 0 from the and and in a in  for a-b,10101600 a. 1/1/8/30424251 (3. patient and a  (1, patient,  at  a-a or, 1 for a- 2 for a for  a for the and for a week at for for 122010285255 for for a for the a [3 for a for 020025 ( a for [0 ( a and [for for a and a,  for a ( a,26-830 0  an in -d-a for the and for for for a. for the for and for for for the. orness,.  and and., and for. (1 and for a a with. for a. for with in with for for for the with for for for a a and a, a and 8-0 3 and-1 and and (: ( [ 1.: : c c: a: the:: C - :  : An An An. [: for a, an c for the: a: for a: an-  for: for for for a with for, C for: an  for. for:: for the for the for. for for 212 for for-0 for for for for for for and for for for for:- for for for and for [ c for 1 in:: C is [ was [:  [::: c for a [-1  and [ is- 11253-1- c (-. and- S (.- S. [ and,  cm in [ and and  [ c [ and. c c and  c11. 11/0...-11- 110616 and-1 [ after ( and- (,  and and and -  cm, [ and [ and and,, [ cm [ [ and with,, c with - c and. C -1059516164122-1 [ - at [ (  or at [ c (-2 [  [-1 ( [ [ [ [ and,  (1 [c, cm c. and cm1201 C1 C2 H1 C1 I H2 [ c 11 cm c [201 C02211 I55811 and C2 S1 C1 I    S H and   for 4 85 511 I0021 S I S2 for  I for C I  S H S1  C1-  1 2  H1 C1 H C   0  C. S  H0  H 1 C.1 S C H  H  [ 0 8 5 95 C 1 I1 1 2 H21 H0 C  H1 and I and1 H31 15 14 C 11 I and H C I  C H1 - H H: C H 4 0 0 R H I  M C1 C H H  C: H :21 I1 I I21 C1 (1 C   C1 H  for  H C C M1  for for for H C H1 (  M2   [.  M MC  m MC [1 M1 CC111 CC12 9025 H16 C1 0   H C0 MC S  I  L I L0 I of H of  of  of H of of H M 0 H  S C 4 H C1 H C2 of8 of1 C C8 H18 H C C3 S C040 H4 and  C6 C1 H1 C4  H1 or 0 S H C C 1 C H H1 H11 S 1 5 and (4 C5 H  C CC CC H C P A1 S and C1 CA C S P1 H 1 and C P C H I C ( C C H and CA H1 H C  S   C C S C H [ H with C C C S C and H  C [ C A P  P  H C S C C1 (  [ H  S H H H 1 ( [2 CA C2 C. C  L  C H C4 and C of H of L of 1 [ C A C  C C C C  C H C A C C Of of C of  of I C S of of C of M I C A  (  C H  C S C C  [ C I H - C  C ( H C C C C C C a S H C C C  R - T H C of C I T I of M C S C T C C H C C C and C C C  C H C I M C C C of A M I [ S C (1 I C C C and  A C C C C of of of ( of C  C A H C C F C C I C C  C M C C C I C I of I S T  C  C C S H C C M M P C/ C A C   C  C C As T S C S C A C C T C I C C A C S C S C P of H H C of of of I H of of of C T M C A A H M H C S C C. M S H- H. C S C C